Serotonin Uptake InhibitorsSerotoninAntidepressive AgentsFluoxetineCitalopramAntidepressive Agents, TricyclicParoxetineAntidepressive Agents, Second-GenerationFluvoxamineSertralineSerotonin Plasma Membrane Transport ProteinsReceptors, SerotoninReceptor, Serotonin, 5-HT1ASerotonin AntagonistsSerotonin SyndromeDepressive DisorderReceptor, Serotonin, 5-HT2ACyclohexanolsDepressive Disorder, MajorDesipramineImipramineSerotonin Receptor AgonistsReceptors, Serotonin, 5-HT1AmitriptylineDepressionReceptor, Serotonin, 5-HT2CMianserinSerotonin 5-HT2 Receptor AntagonistsSerotonin AgentsReceptor, Serotonin, 5-HT1BNortriptylineAdrenergic Uptake InhibitorsReceptors, Serotonin, 5-HT2ClomipramineDothiepinReceptor, Serotonin, 5-HT2BSerotonin 5-HT1 Receptor AntagonistsSerotonin 5-HT2 Receptor AgonistsSerotonin 5-HT1 Receptor AgonistsSwimmingTryptophan HydroxylaseSerotonergic NeuronsAnti-Anxiety AgentsMonoamine Oxidase InhibitorsLofepramine8-Hydroxy-2-(di-n-propylamino)tetralinRaphe NucleiDepressive Disorder, Treatment-ResistantBehavior, AnimalSuicide1-NaphthylamineDrug InteractionsPhenelzinePsychiatric Status Rating Scales5-HydroxytryptophanReceptors, Serotonin, 5-HT3MoclobemideNorepinephrine Plasma Membrane Transport ProteinsPsychotropic DrugsTreatment OutcomeKetanserinHydroxyindoleacetic AcidReceptors, Serotonin, 5-HT4Dose-Response Relationship, Drug5,7-DihydroxytryptamineBrainAnxiety DisordersAntipsychotic AgentsRats, Sprague-DawleyImmobility Response, TonicAnxietyAutoreceptorsPiperazinesDouble-Blind MethodHindlimb SuspensionObsessive-Compulsive DisorderDrug OverdoseNeurotransmitter Uptake InhibitorsSerotonin 5-HT4 Receptor AgonistsCognitive TherapyBuspironeTime FactorsMaprotilinePsychotherapyMotor ActivityPregnancy ComplicationsAnalysis of VarianceFenfluramineDrug Utilization ReviewCyclopropanesHypericumPremenstrual SyndromeMicrodialysisBupropionRandomized Controlled Trials as TopicSexual Dysfunction, PhysiologicalToxicity Tests, SubacuteBiogenic MonoaminesDroxidopaDrug Utilization